Literature DB >> 10651757

The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

J J Conn1, H S Jacobs, G S Conway.   

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus are both common conditions associated with insulin resistance and compensatory hyperinsulinaemia. Previous reports have noted that impaired glucose tolerance and diabetes are common in women with PCOS. In this report we present the results of the converse study: the prevalence of polycystic ovaries in premenopausal women presenting with type 2 diabetes mellitus.
SUBJECTS: Subjects were recruited from a hospital Diabetes Clinic. A search of computerized records identified 49 premenopausal women with type 2 diabetes mellitus being treated with diet alone or oral hypoglycaemic agents of whom 38 (76%) patients agreed to be studied.
DESIGN: A cross-sectional study recording clinical, demographic and anthropometric data. Measurements of fasting metabolic parameters, reproductive endocrine profiles and ovarian dimensions were taken.
RESULTS: Eighty-two percent of women with type 2 diabetes mellitus had polycystic ovaries on ultrasound. Of these women, 52% had clinical evidence of cutaneous hyperandrogenism and/or menstrual disturbance. Correlations between metabolic and reproductive parameters were consistent with a stimulatory action of insulin on the ovary. There was no significant difference between the PCO and non-PCO groups with respect to metabolic profiles.
CONCLUSIONS: Women with type 2 diabetes mellitus have a higher prevalence of polycystic ovaries than that reported in the general population. Not all women with hyperinsulinaemia due to type 2 diabetes mellitus, however, develop PCO suggesting that hyperinsulinaemia alone is not sufficient for the expression of this ovarian morphology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651757     DOI: 10.1046/j.1365-2265.2000.00884.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  27 in total

Review 1.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

Review 2.  Ovarian aging in women with diabetes: An overview.

Authors:  Melissa F Wellons; Juliana J Matthews; Catherine Kim
Journal:  Maturitas       Date:  2016-12-02       Impact factor: 4.342

Review 3.  The metabolic syndrome in polycystic ovary syndrome.

Authors:  P A Essah; J E Nestler
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

4.  Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.

Authors:  R Saxena; C K Welt
Journal:  Acta Diabetol       Date:  2012-03-03       Impact factor: 4.280

5.  Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls--a 2 year follow-up study.

Authors:  M K C Nair; Princly Pappachan; Sheila Balakrishnan; M L Leena; Babu George; Paul S Russell
Journal:  Indian J Pediatr       Date:  2011-07-16       Impact factor: 1.967

Review 6.  Insulin resistance in PCOS.

Authors:  Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 7.  Metformin and gestational diabetes.

Authors:  Charles J Glueck; Naila Goldenberg; Patricia Streicher; Ping Wang
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

8.  Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population.

Authors:  Yan Yang; Jie Qiao; Mei-Zhi Li
Journal:  Reprod Biol Endocrinol       Date:  2010-10-22       Impact factor: 5.211

Review 9.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 10.  Glucose intolerance states in women with the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.